You are cordially invited to the Satellite Symposium CD30 testing: an important step towards precision medicine in haematological malignancies, which will be held on Saturday 3rd September 2016. This symposium is organized by Takeda Oncology and Seattle Genetics* during the
18th Meeting of the European Association for Haematopathology (EAHP)
in Basel, Switzerland.
The aim of the symposium is to highlight the role of CD30 immunohistochemistry in the diagnosis of suspected lymphomas, including PTCL, ALCL, HL, and DLBCL. Together, we will discuss the importance and challenges of accurate lymphoma subclassification, Furthermore, we will address how CD30 pathology has evolved over the past years, and how it could continue to evolve in years to come.
During this interactive symposium, you will have the opportunity to engage in the discussions and interact with the participating experts.
We look forward to welcoming you to this stimulating and highly informative event.
|Stefano Pileri, MD
European Institute of Oncology
University of Bologna
|Randy Gascoyne, MD
BC Cancer Agency